Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5697
Abstract: Little is known regarding associations between peripheral blood biomarkers (PBBMs) and survival, response, and toxicity in recurrent/metastatic head and neck squamous cell carcinomas (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs). read more here.
Keywords: checkpoint inhibitors; head neck; treated immune; immune checkpoint ... See more keywords
Predictive impact of prognostic nutritional index in patients with cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2023 at "Nutrition and cancer"
DOI: 10.1080/01635581.2023.2203355
Abstract: A few previous studies have investigated the prognostic value of the prognostic nutritional index (PNI) in patients treated with immune checkpoint inhibitors (ICIs); however, the results are inconsistent. Therefore, this study aimed to clarify the… read more here.
Keywords: checkpoint inhibitors; immune checkpoint; prognostic nutritional; treated immune ... See more keywords
Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2017.1336088
Abstract: ABSTRACT Introduction: Immune-related neurologic toxicities are uncommon but serious adverse events that may be associated with the use of immune checkpoint inhibitors. The objective of this review is to assess the incidence and risk of… read more here.
Keywords: immune checkpoint; checkpoint inhibitors; patients treated; immune related ... See more keywords
Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies
Sign Up to like & getrecommendations! Published in 2023 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofad164
Abstract: Abstract Cytomegalovirus (CMV) infection/disease has been repeatedly reported in patients treated with immune-checkpoint inhibitors (ICIs) and most commonly involves patients with relapsed/refractory (R/R) immune-related adverse events (irAEs). In the current study, we present a patient… read more here.
Keywords: checkpoint inhibitors; immune checkpoint; treated immune; patients treated ... See more keywords
640 Characterizing severe acute kidney injury in patients treated with immune checkpoint inhibitors
Sign Up to like & getrecommendations! Published in 2020 at "Journal for ImmunoTherapy of Cancer"
DOI: 10.1136/jitc-2020-sitc2020.0640
Abstract: Background Renal immune-related adverse events (irAEs), are relatively rare in patients treated with immune checkpoint inhibitors (ICIs). This retrospective analysis characterizes the etiology of severe acute kidney injury (AKI) in patients treated with ICIs at… read more here.
Keywords: immune checkpoint; checkpoint inhibitors; patients treated; etiology ... See more keywords
Abstract 15678: In Patients Treated With Immune Checkpoint Inhibitors, Myocarditis is Infrequent Compared With Other Cardiovascular Events
Sign Up to like & getrecommendations! Published in 2020 at "Circulation"
DOI: 10.1161/circ.142.suppl_3.15678
Abstract: Introduction: Cardiotoxicity with immune checkpoint inhibitor (ICI) treatment has predominantly focused on myocarditis, which has been estimated to affect ~1% of treated patients. To contextualize ... read more here.
Keywords: patients treated; checkpoint; abstract 15678; immune checkpoint ... See more keywords
Hyperprogressive disease in patients with recurrent high grade gliomas treated with immune checkpoint inhibitors or other therapies.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e13575
Abstract: e13575 Background: Hyperprogressive disease (HPD) has been described in solid tumor patients treated with immune checkpoint inhibitors (ICI). HPD is defined as a ≥2-fold increase in tumor growth rate (TGR) following initiation of ICI. HPD… read more here.
Keywords: immune checkpoint; hyperprogressive disease; control group; hpd ... See more keywords
Host metabolic factors and prognosis in patients treated with immune checkpoint inhibitors for advanced malignancies.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e14162
Abstract: e14162 Background: It is well established that an altered host metabolism has an impact on cancer outcome, possibly mediated by several mechanisms, including hyperglicaemia, hyperinsulinemia and presence of chronic inflammation. The aim of our analysis… read more here.
Keywords: immune checkpoint; treated immune; cancer; checkpoint inhibitors ... See more keywords
Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Immunotherapy"
DOI: 10.2217/imt-2021-0207
Abstract: Aim: We aimed to assess the prognostic value of pretreatment hematological biomarkers in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICIs). Methods: PubMed, Web of Science and Scopus databases were… read more here.
Keywords: renal cell; checkpoint inhibitors; immune checkpoint; treated immune ... See more keywords
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors.
Sign Up to like & getrecommendations! Published in 2022 at "Immunotherapy"
DOI: 10.2217/imt-2021-0333
Abstract: Tweetable abstract Herpes zoster (HZ) is a vaccine-preventable disease, but the role of the vaccine in cancer patients during immunotherapy (ICIs) is still unknown. The clinical and economic consequences of HZ and the increased use… read more here.
Keywords: tumors treated; patients solid; treated immune; zoster patients ... See more keywords
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.830627
Abstract: Purpose We explored imaging and blood bio-markers for survival prediction in a cohort of patients with metastatic melanoma treated with immune checkpoint inhibition. Materials and Methods 94 consecutive metastatic melanoma patients treated with immune checkpoint… read more here.
Keywords: immune checkpoint; treated immune; metastatic melanoma; checkpoint inhibition ... See more keywords